Newsroom

Enveric Biosciences News

Media & Insights

Press Releases

Enveric Biosciences and MagicMed to Participate in June 2021 Investor and Industry Conferences
June 03, 2021

Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives
May 24, 2021

Enveric Biosciences Reports First Quarter 2021 Financial Results
May 18, 2021

Enveric Biosciences Appoints Dr. Arash Asher to Scientific Advisory Board
May 12, 2021

Enveric Biosciences to Participate in the Planet MicroCap Showcase on April 21st
April 14, 2021

Enveric Biosciences Appoints Carter Ward as Chief Financial Officer
April 12, 2021

Enveric Biosciences Reports Full Year 2020 Financial Results and Provides Shareholder Update on its Accomplishments in 2021
April 01, 2021

Enveric Biosciences Appoints Dr. Douglas D. Lind to Company's Board of Directors
March 18, 2021

Enveric Biosciences to Participate in Upcoming Investor Conferences in March
March 15, 2021

Enveric Biosciences Signs Definitive Agreement to Acquire Exclusive License for Novel Molecules from Diverse Biotech
March 10, 2021

Featured Multimedia

Featured In the News

Enveric Biosciences + MagicMed on Recent Acquisition Announcement, Mind and Body Clinical Pipeline [SNN]

EnvericJune 9, 2021

Featured In the News

Enveric Biosciences CEO Describes How the Group Has ‘Multiple Shots on Goal’ with Current Pipeline [Proactive Investors]

InvestorsApril 7, 2021

Featured In the News

David Johnson, Chairman and CEO of Enveric Biosciences [The Green Rush Podcast]

InvestorsMarch 25, 2021

Media Coverage

Media Contact

Subscribe to Receive News Alerts

Full Name

Email *

Select your notifications *

Press Releases

SEC Filings

Stock Quotes